Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy
Chemotherapeutic nanoformulations, which can induce the immunogenic death of tumor cells, have attracted increasing attention for their abilities to enable and potentiate combination chemoimmunotherapy. Immunogenic cell death (ICD) causes the release of tumor-associated antigens, tumor-specific anti...
Main Authors: | Jianhua Liu, Zhongmin Li, Duoyi Zhao, Xiangru Feng, Chunxi Wang, Di Li, Jianxun Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Materials & Design |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0264127521000186 |
Similar Items
-
Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
by: Jiaqi Zhai, et al.
Published: (2023-04-01) -
Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
by: Xiaoxian Huang, et al.
Published: (2022-12-01) -
Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach
by: Fugen Wu, et al.
Published: (2025-02-01) -
Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer
by: Yuhang Fang, et al.
Published: (2022-10-01) -
Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
by: Tong Gao, et al.
Published: (2023-10-01)